Results 1 to 10 of about 13,488 (162)
Carelizumab and rivoceranib for advanced extramammary Paget's disease: an investigator-initiated multicenter, single-arm, phase II trial. [PDF]
Zhang S +6 more
europepmc +1 more source
Hundt Marianne
doaj +1 more source
Schwarz-Friesel Monika
doaj +1 more source
Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease. [PDF]
Zhang S +8 more
europepmc +1 more source
Schäfke Werner
doaj +1 more source
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study. [PDF]
Wei X +10 more
europepmc +1 more source
Larsen Niels-Erik
doaj +1 more source
Machine learning identifies a distinct microbiota signature in immune checkpoint inhibitor colitis compared with inflammatory bowel disease. [PDF]
Barberio B +17 more
europepmc +1 more source
Tummuseit Katharina
doaj +1 more source

